Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Padagis US LLC, priced at $4.3428 per ML under NDC 00574403110. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Feb 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Padagis US LLCNDC
00574403110
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA212715FDA Approved
2/11/2022
TE Code
AB
On Market Since
3/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 67.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3428 per ML |
|---|---|
| All-time high | $13.3557 (Oct 12, 2022) |
| All-time low | $2.8218 (Nov 20, 2024) |
| 52-week high | $4.9644 |
| 52-week low | $4.1561 |
| Median price | $4.8616 |
| Average price | $5.8029 |
| Largest weekly change | +67.2% (Aug 23, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Padagis US LLC, is $4.3428 per ML (NDC 00574403110), effective Aug 19, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 67.5%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Jun 1, 2022, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $2.8218 (Nov 20, 2024) to a high of $13.3557 (Oct 12, 2022), with a median of $4.8616 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOBRAMYCIN-DEXAMETH OPHTH SUSP, is $4.2681 per ML — about 2% below TOBRAMYCIN-DEXAMETH OPHTH SUSP.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 00574403110) is labeled by Padagis US LLC, and CMS classifies it as a generic product.